Our History

From a small beginning that was initiated way back with the post acquisition of majority shareholding of Dabur Pharma by Fresenius Kabi, the Company has  indeed come a long way and established itself as a leading player in the field of oncology generics. Fresenius Kabi Oncology Limited has innovated and developed many life-saving products for cancer patients. We are a company with rich and diverse corporate heritage and with this prophecy we have strived and continued to provide unmatched facilities for R&D and manufacturing in the diverse field of Oncology Generics and its intricate field of research.

Year Successful Development
2003
Dabur India Ltd. spins off the pharmaceutical business into Dabur Pharma Limited.
2008
The Burman family, promoters of the Dabur Pharma Group divested its entire stake in Dabur Pharma Ltd. to Fresenius Kabi, a business segment of Fresenius SE & Co. KGaA, a German Multinational with business interests across the globe.
2009
Post integration with Fresenius Kabi, the name of the Company was changed in order to synchronize the same with Fresenius Kabi.
2010
Opening of newly developed premier Innovation & Development Center and Corporate Office at Gurgaon.
 

© All Copyright Reserved | Fresenius Kabi Oncology Limited 2012
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 8.0+ and Firefox 3.0+